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Background: When considering the principle of medical confidentiality, disclosure of genetic information
constitutes a special case because of the impact that this information can have on the health and the lives of
relatives. The aim of this study is to explore the attitudes of Turkish physicians and patients about sharing
information obtained from genetic tests.
Methods: The study was carried out in Kocaeli, Turkey. Participants were either paediatricians and gynaecologists
registered in Kocaeli, or patients coming to the genetic diagnosis centre for karyotype analysis in 2008. A
self-administered paper questionnaire was given to the physicians, and face-to-face structured interviews were
conducted with patients. We used a case study involving a man who was found to be a balanced chromosome carrier
as a result of a test conducted after his first baby was born with Down's syndrome. However, he refused to share this
information with his wife or his siblings. Percentages of characteristics and preferences of the participants were
calculated, and the results were analysed using Kruskal-Wallis test.
Results: A total of 155 physicians (68% response rate) and 104 patients (46% response rate) were participated in the
study. Twenty-six percent of physicians and 49% of patients believed that genetic information belongs to the whole
family. When participants were asked with whom genetic information should be shared for the case study, most of the
physicians and patients thought the physician should inform the spouse (79%, 85%, respectively). They were less likely to
support a physician informing a sibling (41%, 53%, respectively); whereas, many thought the testee has an obligation to
inform siblings (70%, 94%, respectively).
Conclusions: Although Turkey’s national regulations certainly protect the right of privacy of the testee, the participants in
our study appear to believe that informing the spouse, who is not personally at risk of serious damage, is the physician’s
responsibility, while informing siblings, is the testee’s responsibility. Therefore we believe that opening ethical discussions
with clinicians about the sharing of genetic information, establishing guidelines for practice and sharing these guidelines
and the reasons behind them with the wider population, will help to pre-empt ethical dilemmas.Background
When considering the principle of medical confidential-
ity, it is argued that disclosure of genetic information is
a special case because of the impact that this informa-
tion can have on the health and lives of relatives [1,2].
This claim triggers discussions about exceptions to the
principle of medical privacy (as outlined within the* Correspondence: aslyakcay@yahoo.com
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article, unless otherwise stated.context of psychiatric care and the care of people with
HIV/AIDS [3]) in relation to genetic information. Is it
possible to apply the previously established condition
that disclosure of information is permitted if there is ‘a
clear and present danger’ which can only be avoided by
this disclosure [4], to the sharing of genetic information?
Or should we establish new rules for genetic information
which enable an individual to make informed choices
whether or not the damage can be prevented?
The answer to these questions will be determined by
whether we take the Enlightenment-rooted individual of
Anglo-Saxon culture or the family as the unit of privacyntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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tized in the USA where liberal individualist ethics is
dominant, there is an entirely different perspective on
sharing genetic information in Japan, where Confucian
ethics are dominant and family relationships more
central [6]. Even within Western societies, there are
different views about the ethics of sharing genetic infor-
mation, all of which may be reasonable and well
thought-out. For example, while Australia and Israel
accept the disclosure of genetic information even in the
cases in which the risk is not clear, including cases in-
volving unborn babies, the consent of the patient is an
absolute pre-requisite in Turkey and France [7-9].
These differences could risk opening the door to eth-
ical relativism, and responding to these conflicts involves
a re-examination of principlism and openness to the
possibility of applying alternative ethical approaches,
other than liberal individualism [10]. It is now beginning
to appear that, for the time being at least, the traditional
medical targets of treatment and cure have been super-
seded by targets of diagnosis and prevention which rely
heavily on the free availability of medical genetic infor-
mation. This shift in emphasis has resulted in a redefin-
ition of what constitutes ‘benefit’ and what constitutes
‘harm’ where genetic information is concerned. These
revised, and culture-specific, definitions of benefit and
harm in the context of disclosure of genetic information
[11] may contribute to the drawing up of new, more
comprehensive rules and guidelines for treating sensitive
genetic information.
This new approach argues that the opinion of a major-
ity of both directly and indirectly affected individuals
will be crucial in establishing the rules governing the
disclosure of genetic information. For example, although
the most common model of the family in Turkey is no
longer an extended family group but rather a modern,
nuclear group [12], a quarter of all Turkish marriages
are still consanguineous, mainly between first cousins
[13]. In addition to this, although rapid social and cul-
tural change has lessened the importance of the family
as a unit, and has hastened the decline of group con-
sciousness and loyalty within the family group, while the
blurring of gender roles has also changed the dynamics,
the family unit is still the most important primary and
intimate unit within Turkey [14]. The resulting family
structure, with its high proportion of marriages between
cousins, increases the likelihood of babies being born
with genetic defects unless genetic information is shared
in a responsible manner.
Cytogenetic or molecular genetic tests are carried out in
most Turkish medical laboratories and departments of
medical genetics within medical faculties. They are also
carried out in the increasing number of private medical la-
boratories. In certain cases, the difficulties experienced inproviding genetic counselling, where the aim is to give in-
formation about the importance and possible outcomes of
genetic tests, provide a context for a number of ethical
problems. The absence of any national standards for the
use of genetic information makes the field fraught with
difficulties.
The aim of this study is to explore the attitudes of re-
lated parties to the issue of genetic information and how
it should be shared. This exploration is considered with
particular reference to a recent case which took place in
Turkey, and involves subjecting this case to an ethical




This study was acarried out in Kocaeli, the second lar-
gest industrial province in Turkey after Istanbul.
The study was carried out in two phases. The first phase
focused on establishing which areas of specialization most
frequently demand a genetic test. To determine this, we
reviewed annual statistics (in 2008) of the Medical Biology
and Genetics Laboratory - in which molecular genetics and
cytogenetic testing are performed – located within the Fac-
ulty of Medicine of Kocaeli Universityb. It was discovered
that the departments in which genetic testing were most
likely to be requested were (1) obstetrics and gynaecology,
and (2) paediatrics. Professionals specialising in these fields
in the Kocaeli University Hospital were contacted and
asked for write-ups of the cases where they had experi-
enced an ethical dilemma. These case studies were narrated
by the researchers in a manner which brought out the eth-
ical dimension, and this format was finalized between the
researchers and specialists in a face-to-face meeting.
The Case extracted from this process and used in this
study was written up by a neonatologist. It concerns a
person named Mahmut, (All personal characteristics and
names were fictional in this case) who was found to be a
balanced chromosome carrier as a result of a test con-
ducted after his first baby was born with Down's syn-
drome. However, he refused to share this information
with his wife or his siblings. In a balanced translocation,
“pieces of chromosomes are rearranged but no genetic
material is gained or lost in the cell. The individual with
a ‘balanced’ translocation will usually have the correct
amount of genetic information for normal development.
But there is an increased chance that there will be repro-
ductive consequences due to the child receiving an ‘un-
balanced chromosome complement’ – i.e., the child has
more or less chromosomal material than usual [15].”
The second phase, a cross-sectional research study, was
performed in Kocaeli. Two categories of people were in-
vited to participate: (1) all specialists working in the fields
of obstetrics and gynaecology or paediatrics and serving in
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boratory of Medical Biology and Genetics in the Faculty of
Medicine by physicians working in related departments and
who gave their consent for genetic tests. Structured ques-
tionnaires, developed by the researchers, were left for the
physicians to fill in, while the patients and parents were
given structured face-to-face interviews covering the same
series of questions. Patients and parents were informed
about the study, and emphasising voluntary participation,
oral informed consent was obtained. The physicians were
reminded that returning a completed study form implies
informed consent. This study was approved by the Human
Research Ethics Committee of Kocaeli University (Decision
Number: 2008-İAEK3/12).
Questionnaire and data analysis
The questionnaires for the study were developed in the fol-
lowing way. Firstly, ethical issues arising from genetic test-
ing were identified through a literature search. These issues
were then used to gather opinions from medical ethics spe-
cialists, medical biology and genetics specialists, gynecolo-
gists and obstetricians and child health and disease experts,
in order to create a draft questionnaire. The draft question-
naires were shaped based on the characteristics of the two
groups that would be targeted by the study and were
checked by an expert in the Turkish language. Pilot studies
were conducted involving two groups, one of ten physicians
and the other of ten patients to ensure clarity of the ques-
tionnaires (Additional files 1, 2, 3 and 4).
In this main study the questions which explored the
socio-demographic and professional characteristics of
the groups and the attitudes of these groups regarding
the ownership of genetic information both in general
and with specific reference to the case study were used.
The first four statements about the case were related to
the ethical obligations of the physician, the fifth state-
ment was related to Mahmut's personal responsibility
and the last statement concerned the obligations of the
state in terms of social justice. The relation between the
answers of the parties to the questions and the personal
characteristics of the participants and the professional
features of the physicians, and the relation between the
information level of the patients/parents and the atti-
tudes of the parties towards the issue of ownership of
genetic information were analyzed with the Kruskal-




26-year-old Nurgül gave birth to a premature baby. The
baby had hypertelorism, simian crease, endocardial cushion
defects, chronic lung disease and pulmonary hypertension.
A chromosome anomaly was detected in the test which hadbeen suggested by Dr. Elif, the neonatalogist, who suspected
that the baby might have Down syndrome. The mother, who
was hoping to have another baby in the future, insisted that
the cause of the Down syndrome be investigated and asked
for tests to be carried out both on her and on her husband.
Realizing that the father was unwilling to participate, the
neonatalogist Dr. Elif gave information to the spouses about
prenatal diagnostic tests which could be carried out in the
course of a future pregnancy. Two weeks later, Nurgül and
her husband Mahmut, who could not withstand his wife’s
determination, applied to have the test. Mahmut was iden-
tified by the test results as a balanced translocation carrier.
Mahmut has younger siblings, all of whom may wish to
have children in the future. Dr. Elif suggested to Mahmut
that it would be helpful to them if he were to share this in-
formation about his condition with his first degree relatives
and his wife who was keen to start a second pregnancy.
However, Mahmut said that his communication with his
relatives was not at all good anyway, and he was not plan-
ning to have a second baby. For these reasons, he refused to
tell his family members, or his wife, about the test result.
Of the physicians who were approached to take part in
the research, 155 (68%) participated. The age range of
this group was 30–60 years, with a mean age of 44.4 ±
10.3. Socio-demographic characteristics of the participat-
ing physicians are shown in Table 1.
Of the 155 participating physicians, 80.6% (n = 125)
stated that they suggest genetic testing to their patients
as part of their daily practice, while 40% of the physi-
cians (n = 50) stated that they suggest genetic testing to
their patients at least once a month.
When the physicians were asked what they thought
about the ownership of genetic information, 62% of
them stated that it belongs to the individual, 26% of
them said it belongs to the family and 12% of them said
that it belongs to humanity.
The average of age of the 104 patients/parents (46%
response rate) participating in the research was 32.4 ±
7.0 (18-47). As all participants (whose characteristics are
shown in Table 2) had been pre-diagnosed, they had all
already given blood for karyotype analysis either on their
own or behalf of that of their children. Nearly two thirds
– 64.4% (n = 67) – of the participants had been referred
to the genetics laboratory from the department of ob-
stetrics and gynaecology, and the remaining 35.6% (n =
37) had been referred by the department of paediatrics.
Only 58% of these participants said that they had been
given sufficient information about the test. When the
patients were asked about the ownership of the genetic
information; 39% stated that it belongs to the individual,
49% to the family and 12% to humanity.
The responses of the participants to the case study,
and the relationship of these responses to the independ-
ent variable are shown in Table 3.
Table 1 Personal and professional characteristics of the
physicians (N = 155)







50s and over 42 (27.1)
Children
Has child/children 131 (84.5)
No children 24 (15.5)
Area of Specialty
Paediatrics 82 (53.0)
Gynaecology and Obstetrics 73 (47.0)
Years in the Field
≤ 10 years 72 (46.5)
>10 years 83 (53.5)





Table 2 Personal characteristics of those undergoing
genetic testing (N = 104)









Has child/children 48 (46.2)
No children 56 (53.8)
Level of education
≤8 years 52 (50.0)
9-11 years 31 (29.8)
≤12 years 21 (20.2)
Information level about the genetic tests
Sufficient -
Medium 22 (21.2)
Not sufficient 36 (34.6)
No knowledge 46 (44.2)
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statement that Dr. Elif should respect Mahmut’s decision.
Men were more likely to respect Mahmut's decision
than women in the group of patients (Table 3).
The majority of both groups agreed with the statement
that Dr. Elif should notify Mahmut’s wife about the re-
sults despite Mahmut’s request to keep his genetic infor-
mation confidential. Physicians who were over fifty years
old and believed their knowledge about genetic testing
to be ‘sufficient’ were the most likely group to agree with
the statement about notifying Mahmut’s wife (Table 3).
The majority of participants disagreed with the state-
ment that Dr. Elif should avoid revealing the truth to
Mahmut’s wife in the interests of family unity; however
men in the patient group were more likely than women
in the same group to agree with this statement.
The statement Dr. Elif has a responsibility to warn
Mahmut’s siblings about the genetic test results provoked
a mixed reaction with agreement from 41% of the physi-
cians and 53% of the patient group. The older and more
experienced the physicians were, the more likely they
were to agree about the importance of warning
Mahmut’s siblings. In addition, the idea that it was the
physician’s responsibility to inform siblings was one that
found particular support from physicians and from thosepatients who think genetic information belongs to the
family.
The majority of the participants agreed with the state-
ment that Mahmut has an obligation to reveal the truth
to his siblings and to advise them to take test. Most of
the physicians who believe genetic information belongs
to humanity agreed with the idea that the responsibility
of warning siblings belongs with Mahmut himself.
The last question about this case was whether there
was an obligation for the state to provide free genetic
testing for people in the case of chromosomal abnormal-
ities which affect subsequent generations. The response
to this was a positive one with 78% of the physicians and
94% of the patients agreeing with the idea that the state
should be obliged to make such tests available free of
charge. No relationship was detected between these re-
sponses and the independent variables. Those patients
who disagreed with this idea thought that the state
should only pay for testing those people who could not
afford to pay for the tests themselves.
Limitations
There were several limitations to this study. First, since
we conducted the study only in Kocaeli, the findings
cannot be generalised to the Turkish population as a
whole. Second, there is potential for selection bias as the
participants were those who were willing to give their
Table 3 The relation between the responses to the statements in the case and the personal and/or professional characteristics of the parties
Statements Physicians n (%) Patients n (%)
The physician should respect Mahmut's decision I agree 39 (25.8) 13 (12.5)
Neutral 24 (15.9) 7 (6.7)
I disagree 88 (58.3) 84 (80.8)
Significance (N = 151; N = 104) NS Gender, p = .013
The physician should inform the spouse I agree 117 (78.5) 88 (84.6)
Neutral 16 (10.7) 4 (3.8)
I disagree 16 (10.7) 12 (11.5)
Significance (N = 149; N = 104) Age, p = .037; Level of information, p = .024 NS
The physician should avoid revealing the truth to the spouse to protect the unity of the family. I agree 15 (10.1) 10 (9.6)
Neutral 21 (14.1) 2 (1.9)
I disagree 113 (75.8) 92 (88.5)
Significance (N = 149; N = 104) NS Gender, p = .005
The physician should inform the siblings I agree 61 (41.2) 55 (52.9)
Neutral 43 (29.1) 5 (4.8)
I disagree 44 (29.7) 44 (42.3)
Significance (N = 148; N = 104) Age, p = .007; Years in department, p = .007; Ownership, p = .002; Ownership, p = .025
Mahmut has an obligation to inform his siblings and to advise them to take test I agree 106 (70.2) 98 (94.2)
Neutral 26 (17.2) 3 (2.9)
I disagree 19 (12.6) 3 (2.9)
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expressed by the participants may not accurately reflect
what would happen in a real world situation, rather than
a hypothetical exercise.
Discussion
The extent of the individual’s right to privacy, and the ex-
tent to which the physician has an obligation to protect the
third parties involved, constitute the ethical dilemma at the
heart of the case-study. -One quarter- of the physicians sur-
veyed and -one eighth- of the patients believed that
Mahmut had a right to expect this information to be kept
confidential. The majority of those who supported this view
were male patients. The responses of participants to ques-
tions about the issue of protecting the unity of the family
overlapped with the responses about the respect for the
privacy.
Effect of gender on disclosure of third parties
Gender has a clear effect on attitudes towards concealing
this information, both in our study and in a similar research
study carried out in France. In both studies, a substantial
proportion of the men surveyed were sympathetic to the
idea that test results should not be disclosed if the subject
of the tests so wished [16]. Although it could be argued that
this sympathy on the part of males is likely to be affected
by the patient’s gender, this result is also consistent with
other research findings which show that women are more
likely to take responsibility for warning others who might
also be at risk [17,18]. When considered from the perspec-
tive of feminist ethics, this finding seems to support the
idea that it is characteristic of women to protect everyone's
benefit, take care of other people's needs and sympathize
with others [19]. For example, it has been reported in a
Canadian study that, among the individuals who have
BRCA1/2 mutation, women are more willing to share the
information about risk by contacting others, even distant
relatives [20].
Medical confidentiality versus protecting others
The obligation of protecting patient confidentiality, which
is also a requirement of respecting patient autonomy and
privacy, is an integral part of the duty of medical confidenti-
ality – which itself is one of the earliest obligations of medi-
cine. The main exception to this duty arises when third
parties might be exposed to an unacceptable degree of
damage, especially within the context of HIV/AIDS or
psychiatry [4]. In Turkey there are no legal standards about
a duty to warn in such situations. Although there is a bill of
law about HIV/AIDS in which partner notification in lim-
ited situations is mentioned, it is not yet legalized [21].
There are also public health reporting requirements for
some contagious diseases; however, these notifications are
only required for establishing health policies and do notinclude partner notification [22]. On the other hand, both
physicians and those who have had genetic tests seem to
find the idea of sharing the test results with a spouse more
appealing than the idea of sharing them with another indi-
vidual, such as a sibling, who runs the risk of experiencing
physical or social damage on the basis of these genetic test
findings. This situation, which cannot be evaluated within
the scope of the available exemptions of the medical confi-
dentiality, is noteworthy. Although the carriers of balanced
chromosome will not have a risk of experiencing a serious
medical problem themselves, it is possible that their chil-
dren will. A definite decision needs to be made, therefore,
about whether this risk is sufficient to allow violation to the
principle of medical confidentiality [16,23], because con-
cealment of a secret such as that involving Mahmut may
cause harm and considerable distress to any third parties
who may be affected.
There is a conflict here between the obligations of the
physician in terms of medical confidentiality and the ethical
obligation to prevent other people from incurring damage
or minimizing the damage. There is also a conflict between
the principles of nonmaleficience and justice [3]. Although
Mahmut’s request for his test result not to be disclosed to
his wife was not met with approval from the participants in
our study, there is only one article in the Regulation on the
Centres for Diagnosis of Genetic Diseases (the only regula-
tion produced on ethical issues related genetics within
Turkey) covering this topic. The article states that "…gen-
etic test results cannot be revealed to third parties without
the consent of the person [9]”. This ethical approach is sup-
ported by the Regulation of Patients’ Rights [24] and the
Turkish Medical Association’s (TTB) Code of Medical Eth-
ics [25] within the scope of the obligation to respect patient
privacy and confidentiality. The only exemption stated in
the TTB’s Code of Medical Ethics is when the life itself is
endangered: "The obligation of confidentiality of the phys-
ician becomes invalid in circumstances where keeping con-
fidentiality would put the life of the patient or other people
in jeopardy (article 9)". The exemptions in which the breach
of the confidentiality can be approved ethically are
grounded in the possibility and degree of damage in these
ethical codes.
While the current regulations include this proviso, an
ethical concern arises from the fact that physicians (in
common with the patients) prefer to disclose the genetic
information to the patient’s wife rather than to his sib-
lings. Older, more experienced physicians – who pre-
sumably have more knowledge about the implications of
genetic testing – share this concern. The duty of the
physician regarding the prevention of damage to third
parties is likely to make them more aware about people
who are at serious risk of damage. Therefore, the benefit
and harm of revealing or hiding the information should
be evaluated in each case with respect to the principle of
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harm resulting from sharing the information with the
spouse is evaluated objectively, the fact that the mother
who gives birth to a baby with Down syndrome is
already at higher risk than other mothers in her next
pregnancies [27], makes it difficult to justify violating
Mahmut’s confidentiality when considering the ‘clear
and present danger’ rule. Nevertheless, the physician is
expected to encourage Mahmut to discuss his results
with his wife Nurgül so that she can make informed de-
cisions about future pregnancies and have choices about
whether to give birth to a baby with Down syndrome.
This will also increase honesty within the marriage. In
addition, the physician should encourage Nurgül to
speak about her own health condition, and her plans
about having children, with her husband [5].
The patients interviewed felt less responsible for warning
siblings who might be at risk of being damaged by these re-
sults than they did about warning the spouses. However,
physicians who were in their fifties and who were more ex-
perienced were more likely to give serious consideration to
the potential harm to other people. The belief that the test
results belong to the family as a whole appears to be behind
the willingness to disclose information to siblings rather
than to the spouse. Our opinion is that the number of par-
ticipants in our study who felt that the primary responsibil-
ity for informing siblings lay with Mahmut rather than with
the physician supports this theory (Table 3). Although some
of the patients appear to hold the view that it should be
Mahmut who should inform his siblings about the result of
the genetic testing, rather than the physician, because it
would be difficult for physicians to communicate with the
patient’s relatives in their intense work environment, the
physicians who believe that genetic information belongs to
the family as a whole are even more likely to support this
course of action (Table 3).
Research studies carried out with groups of balanced
chromosome carriers in the USA [28] and England [29]
found that brothers, sisters and other relatives were
likely to be given information, in contrast to the studies
carried out in Germany [30] and France [16]. In these
latter countries, as in our case, the patients being tested
refused to inform their relatives. The reasons they gave
for their decision were that they want to take decisions
about their family planning with reference to the present
situation rather than to the future [16]; psychological re-
actions like guilt and shame; the fear of being stigma-
tized in the family on account of being a carrier; feeling
inadequate to the task of informing relatives, or denial
of the results and their implications and subsequent de-
pression [30]. All of the participants in a Canadian study
on patients with breast cancer felt not only that they had
a responsibility to share the information but also that
their relatives have the right to know [20].It is important to determine the degree of harm that
can be caused by the failure to share information, and
seek reliable and valid evidence about whether the shar-
ing of information can help prevent harm before making
a decision about genetic information which could violate
the principle of medical confidentiality [23,26,31]. Al-
though the degree of potential risk of harm may change
with time, as the field of medical genetics advances, the
findings currently available indicate that the likelihood
of adults appearing phenotypically normal but carrying
balanced chromosome anomaly is 1/500 in the general
population, and 80% of these cases are hereditary
[29,32]. Consequently, it is possible to discuss certain
risks, such as having a baby with an unbalanced chromo-
some anomaly (10%-15%) [30,32], spontaneous miscar-
riage (25%-50%), infertility, or recurrent miscarriage in
relatives. However, these risks can be prevented with
prenatal or preimplantation cytogenetic diagnostic tests
[30,33,34]. As a result it is argued that, when genetic risk
and diagnosis is taken into consideration, sharing the in-
formation that a person is a carrier of balanced chromo-
some anomaly, even with distant relatives, can be
justified [30]. On the other hand, researches in France
and the USA suggest that some relatives who are in-
formed by the testees do not feel any need to find out
more information [16,30]. The suggestion that testees
cannot inform their relatives effectively [35], or that the
information can be misinterpreted [16], makes it all the
more important that physicians provide relevant know-
ledge to third parties in the interest of preventing harm.
The widely accepted idea that the individual has a moral
obligation to inform his/her relatives [11,17,20,23,36] was
evidently also held by the patients in our research. This
result can be discussed within the framework of the individ-
ual's responsibility to his/her relatives. For example, as
mentioned by Raz and Schicktanz [37], according to Kenen
(1994) and Hallowel (1999) the increase in access to genetic
information also increases the onus on the individual con-
cerned to share his/her genetic information with any rela-
tives who might also be affected, and Konrad (2003) defines
the conflict between the imperative to disclose and the de-
sire to hide the information as a moral conflict. Most of the
German subjects affected by a genetic disorder believe they
have a duty to warn their relatives, especially when prevent-
ive actions can be taken [37]. Informing the people at risk
is also considered less important in our research and in a
study conducted in Australia [11].
On the other hand, those who believe that genetic in-
formation belongs to the family as a whole tend to sup-
port the disclosure of such information, coinciding with
the communitarian ethical approach which pursues the
benefit of all family members who might be affected by
the problems identified [38,39]. In addition to this, the
virtues expected from Mahmut – such as honesty in his
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sharing the truth with his siblings – may provide guide-
lines for ethical behaviour [40].
Confidentiality and insurance coverage of genetic testing
The responsibilities of the state, in terms of enabling ac-
cess to genetic tests and minimizing the damage people
might experience if they lack access to such tests should
be discussed with reference to social justice. The state's
obligation relating to equal allocation of medical re-
sources among the people who have similar needs is
based on social justice. The responsibility of the state to
enable the access to genetic tests not only for those who
can pay but also for those who need them but who can-
not pay [41], is based on an understanding that it is im-
portant to prevent damage, as far as possible, in those
who are most likely to suffer from this damage [42].
The physicians and the patients in our study believed
that, in situations where the reproductive choices for
healthy generations might be affected, the state has an
obligation to provide the relevant genetic tests free of
charge. The regulations in Turkey appear to be compat-
ible with these expectations. Although genetic tests (pre-
natal, cytogenetic and molecular genetic) are covered by
health insurance based on medical need, these regula-
tions also allow people who do not have health insur-
ance to benefit from these expensive tests [43]. However,
physicians and patients in our study believe that the cost
of the tests should be met by the state even if there is no
medical indication, as in our case. In fact, the state pol-
icy with regard to genetic tests/advanced diagnostic tests
is determined by a cost and benefit analysis of genetic
screening programs. The cost-benefit analysis for these
programs is measured by their effectiveness in decreas-
ing the incident and mortality/morbidity of the relevant
genetic disease [44]. For example, the newborn screening
program in Turkey does not include a test for
hemoglobinopathy because such a program would have
a cost-benefit advantage only if the national incidence of
this condition was high. In Turkey, it is low, and so pre-
marital blood tests are considered sufficient [45].
The regulations relating to the coverage of DNA tests,
other than the judicial and medical indications, by health
insurance [46], provide a legal framework in which the
medical profession and the state can work together for
the common good. The evidence-based medical indica-
tion, which should be pursued by the physician in the
decision-making process, is relied upon within the con-
text of the genetic tests, and as long as there is medical
indication, the test fees are covered by health insurance
[46]. cAs a result, this regulation supports the additional
duty of the medical profession, which includes the fair
allocation of medical resources and prevention of their
unnecessary use in terms of the principle of justice,along with the duty to provide medical treatment [47].
As observed in this case study, when there is doubt
about the material benefit of the test, it seems difficult
to justify the test and deem it a fair allocation of medical
resources.
Conclusions
The family unit is still the most important unit among
primary and intimate groups in Turkey [14]. The fre-
quency of consanguineous marriage in Turkey may both
increase the number of the babies born with genetic dis-
orders, and give rise to more conflicts over whether or
not to share genetic information.
In our case study, which is valuable in terms of dem-
onstration of the importance of cultural differences, the
following conclusions were reached:
 Although many physicians believe that genetic
information belongs to the individual, which
suggests they support individual privacy, they also
believe that, in certain situations, it is justifiable to
breach the confidentiality of a testee.
 The majority of the patients interviewed appear to
believe that informing the spouse, who is not
personally at risk of serious damage at present, is the
physician’s responsibility, while informing siblings,
who have the possibility of facing risks, is the testee’s
responsibility. This tendency to believe the spouse
should be informed by the physician may arise from
the importance given to the institution of the family,
and the perception of the family as the keystone of
society in Turkey.
 Finally, the majority of those patients interviewed
believe that it is the responsibility of the state to
provide genetic testing free of charge, even in
situations where medical indication of the genetic
test cannot be presented clearly and cannot be
associated with just allocation of resources. The
Turkish Department of Social Security Institution
prefers to base such decisions upon the clarity of the
evidence that can be gathered and on its
applications. On the other hand, this does not seem
to be an entirely satisfactory solution because of the
concerns for possible discrimination among patients
in the future.
All these results demonstrate the necessity and the im-
portance of informing all parties about the availability of
genetic counselling and testing. Such information has
not as yet been disseminated sufficiently in Turkey. In
addition, we believe that opening ethical discussions
with clinicians about the sharing of genetic information,
establishing guidelines for practice and sharing these
guidelines and the reasons behind them, with the wider
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outlined in the case study, participants prefer breaching
confidentiality in situations like those described the case
story. Although we do not know the reasons underlying
this belief, it is noteworthy and should be considered
when establishing ethical guidelines for exceptions to
medical confidentiality in Turkey.
Endnotes
aThis project, of which only a part is presented here, is
Aslihan Akpinar’s doctoral dissertation titled "Ethics in
Using Genetic Information: Attitudes and Preferences of
Physicians and Testees".
bThe Hospital of Kocaeli University is the oldest re-
search hospital serving the West of the Black Sea Region
and is a center for specialist referrals from the services.
cHowever, the Turkish Department of Social Security
demands the original document containing the test re-
sult before reimbursing costs. This rule, which was ori-
ginally instituted to prevent the unnecessary use of the
genetic tests, should be revised on the basis of potential
damage to the individual.
Additional files
Additional file 1: Physician’s Form in Turkish.
Additional file 2: Physician’s Form in English.
Additional file 3: Patient’s Form in Turkish.
Additional file 4: Patient’s Form in English.
Competing interests
We certify that we have no competing interests in respect of this
manuscript.
Authors’ contributions
AA and NE designed the study and developed the questionnaires. AA did
data collection, statistical analysis, results interpretation and writing up the
manuscript. NE critically evaluated the results and the manuscript. AA was a
research assistant at Kocaeli University when the study was conducted. Both
authors read and approved the final manuscript.
Acknowledgements
We are grateful to Prof. Gülcan Türker, MD. at the Department of Paediatrics of
the Faculty of Medicine at the Kocaeli University, for her assistance in the
presentation and narration of the case. This research was funded by the Unit of
the Scientific Research Projects at the Kocaeli University. (Project Nr: 2008/21).
Author details
1Department of History of Medicine and Ethics, Hacettepe University Faculty
of Medicine, Ankara, Turkey. 2Department of History of Medicine and Ethics,
Kocaeli University Faculty of Medicine, Kocaeli, Turkey.
Received: 20 November 2013 Accepted: 30 April 2014
Published: 16 May 2014
References
1. Knoppers BM: Genetic information and the family: are we our brother’s
keeper? Trends Biotechnol 2002, 20:85–86.
2. Murray TH: Genetic exceptionalism and “Future Diaries”: is genetic
information different from other medical information? In Genetic secrets:Protecting privacy and confidentiality in the genetic era. Edited by Rothstein
MA. New Haven: Yale University Press; 2007:60–73.
3. Beauchamp TL, Childress JF: Principles of Biomedical Ethics. Oxford: Oxford
University Press; 2009.
4. Shah SK, Hull SC, Spinner MA, Berkman BE, Sanchez LA, Abdul-Karim R, Hsu
AP, Claypool R, Holland SM: What does the duty to warn require? Am J
Bioeth 2013, 13:62–63.
5. Wertz DC, Fletcher JC, Berg K: Report of Consultants to WHO, Review of
Ethical Issues in Medical Genetics; 2003. http://www.who.int/genomics/
publications/en/ethical_issuesin_medgenetics%20report.pdf.
6. Macer DRJ: Genetic information and the family in Japan; 2003. http://www.
eubios.info/Papers/nate587.htm.
7. Otlowski M: Australian reforms enabling disclosure of genetic
information to genetic relatives by health practitioners. J Law Med 2013,
21:217–234.
8. Laurie G: Genetic Privacy: A Challenge to Medico-Legal Norms. New York:
Cambridge University Press; 2002.
9. Turkish Regulation on Diagnosis Centres for Genetic Diseases. No. 23368,
dated 10.6.1998.
10. Ashcroft A, Parker M, Verkerk M, Widdershoven G: Philosophical
introduction: case analysis in clinical ethics. In Case Analysis in Clinical
Ethics. Edited by Ashcroft R, Lucassen A, Parker M, Verkerk M, Widdershoven
G. Cambridge: Cambridge University Press; 2005:1–6.
11. Forrest K, Simpson SA, Wilson BJ, Teijlingen ER, Mckee L, Haites N, Matthews
E: To tell or not to tell: barriers and facilitators in family communication
about genetic risk. Clin Genet 2003, 64:317–326.
12. Tezcan M: [Turkish family life through republican period: past, present
and future] Cumhuriyetten günümüze Türk ailesinin dünü, bugünü
geleceği. 2009. http://turkoloji.cu.edu.tr/GENEL/tezcan_aile.pdf.
13. Turkish Regulation on Neonatal Screening Programme. No. 4911, dated
19.12.2006.
14. Celkan HY: [Family as a core element of human culture] Beseri Kültürün
Temel Öğesi Aile. Aile ve Toplum 1991, 1:81–84.
15. The Centre for Genetics Education. Changes to Chromosome Structure
Translocatıons Fact Sheet 7; 2012. http://www.genetics.edu.au/Publications-
and-Resources/Genetics-Fact-Sheets/FactSheet7.
16. Ayme S, Macquart-Moulin G, Julian-Reynier C, Chabal F, Giraud F: Diffusion
of information about genetic risk within families. Neuromusc Disord 1993,
3:571–574.
17. Hallowell N: Doing the right thing: genetic risk and responsibility.
Sociol Health Illn 1999, 21:597–621.
18. Hallowell N, Foster C, Eeles R, Ardern-Jones A, Murday V, Watson M:
Balancing autonomy and responsibility: the ethics of generating and
disclosing genetic information. J Med Ethics 2003, 29:74–83.
19. Verkerk M: A feminist care-ethics approach to genetics. In Case Analysis in
Clinical Ethics. Edited by Ashcroft R, Lucassen A, Parker M, Verkerk M,
Widdershoven G. Cambridge: Cambridge University Press; 2005:133–148.
20. D’Agincourt-Canning L: Experiences of genetic risk: disclosure and the
gendering of responsibility. Bioethics 2001, 15:231–247.
21. Turkish Bill of Law on HIV/AIDS. No. 1960, dated 30.11.2012.
22. Regulation on survey and control of contagious diseases. No. 26537,
dated 30.5.2007.
23. British Medical Association: Human Genetics: Choice and Responsibility. USA:
Oxford University Press; 1998.
24. Turkish Regulation on Patients’ Rights. No. 23420, dated 1.8.1998.
25. Turkish Medical Association: [Code of Medical Ethics] Hekimlik Meslek Etiği
Kuralları; 2012. http://www.ttb.org.tr/kutuphane/h_etikkural.pdf.
26. Sharpe NF, Carter RF: Genetic Testing: Care, Consent and Liability. New Jersey:
John Wiley & Sons Inc.; 2006.
27. Yararbaş K, Ilgın-Ruhi H: Prenatal Diagnosis. Turkiye Klinikleri J Med Sci 2006,
26:666–674.
28. Clarke A, Richards M, Kerzin-Storrar L, Halliday J, Young MA, Simpson SA,
Featherstone K, Forrest K, Lucassen A, Morrison PJ, Quarrell OW, Stewart H:
Genetic professionals' reports of nondisclosure of genetic risk informa-
tion within families. Eur J Hum Genet 2005, 13:556–562.
29. Suslak L, Price DM, Desposito F: Transmitting balanced translocation
carrier information within families: a follow-up study. Am J Med Genet
1985, 20:227–232.
30. Wolff G, Back E, Arleth S, Rapp-Körner U: Genetic counselling in families
with inherited balanced translocations: experience with 36 families.
Clin Genet 1989, 35:404–416.
Akpinar and Ersoy BMC Medical Ethics 2014, 15:39 Page 10 of 10
http://www.biomedcentral.com/1472-6939/15/3931. Lo B: Resolving ethical dilemmas: A guide for clinicians. Philedelphia: Lipincott
Williams & Wilkins; 2013.
32. Uysal A, Uludağ A, Sılan F, Erçelen N, Zafer C, Ozdemir O: Double
translocation: an interesting family history. Balkan J Med Genet 2013,
16:77–80.
33. Kara N, Koçak Đ, Günes SÖ, Ökten G, Sezer Ö, Yiğit S: [Recurrent Abortions
and Balanced Translocation 46, XX, T(3;7) (P21;Q36) Carriers Mother and
Daughter, Two Cases] Tekrarlayan düsükleri olan 46, xx, t(3;7) (p21;q36)
dengeli translokasyon tasıyıcısı anne ve kız iki olgu. Turkiye Klinikleri J
Gynecol Obst 2007, 17:65–68.
34. Rouen A, Hyon C, Balet R, Joyé N, Cassuto NG, Siffroi JP: First Birth after
Sperm Selection through Discontinuous Gradient Centrifugation and
Artificial Insemination from a Chromosomal Translocation Carrier.
Case Rep Genet 2014, doi:10.1155/2014/906145.
35. Blase T, Martinez A, Grody WW, Schimmenti L, Palmer CG: Sharing GJB2/
GJB6 genetic test information with family members. J Genet Couns 2007,
16:313–324.
36. Malm H: Genetic privacy: might there be a moral duty to share one's
genetic information? Am J Bioeth 2009, 9:52–54.
37. Raz AE, Schicktanz S: Diversity and uniformity in genetic responsibility:
moral attitudes of patients, relatives and lay people in Germany and
Israel. Med Health Care Philos 2009, 12:433–442.
38. Doukas DJ, Berg JW: The family covenant and genetic testing. Am J Bioeth
2001, 1:2–10.
39. Gilbar R: The status of the family in law and bioethics. England: Ashgate
Publishing Company; 2005.
40. Gillon R: Families and genetic testing: the case of Jane and Phyllis from a
four-principle perspective. In Case Analysis in Clinical Ethics. Edited by
Ashcroft R, Lucassen A, Parker M, Verkerk M, Widdershoven G. Cambridge:
Cambridge University Press; 2005:165–186.
41. World Health Organization: Proposed International Guidelines on Ethical Issues
in Medical Genetics and Genetic Services. 1998. http://whqlibdoc.who.int/HQ/
1998/WHO_HGN_GL_ETH_98.1.pdf.
42. Rawls J: A Theory of Justice. USA: Harvard University Press; 2003.
43. Turkish Law on Coverage of State Health Insurance. No. 21273, dated
03.07.1992.
44. Grosse SD, Khoury MJ: What is the clinical utility of genetic testing? Genet
Med 2006, 8:448–450.
45. Canatan D, Kose MR, Ustundag M, Haznedaroglu D, Ozbas S:
Hemoglobinopathy control program in Turkey. Community Genet 2006,
9:124–126.
46. Turkish Health Budget Law. Law 2010, No. 27532, dated 25.03.
47. Jonsen AR, Siegler M, Winslade WJ: Clinical Ethics, A Practical Approach To
Ethical Decisions in Clinical Medicine. McGraw-Hill Inc: USA; 2010.
doi:10.1186/1472-6939-15-39
Cite this article as: Akpinar and Ersoy: Attitudes of physicians and
patients towards disclosure of genetic information to spouse and
first-degree relatives: a case study from Turkey. BMC Medical Ethics
2014 15:39.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
